rxstat › Shortages › Tirzepatide

Tirzepatide shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Tirzepatide is in a widespread shortage in Canada. 6 of 6 reported products are affected. Manufacturers have not committed to a recovery date.
Products affected
6 of 6
In shortage since
Jan 22, 2025
Reports on file
12
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MOUNJARO
15MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541106 · since Jan 22, 2025, no end estimate · Other (Please describe in comments)
Active shortage
MOUNJARO
12.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541092 · since Apr 3, 2025, no end estimate · Other (Please describe in comments)
Active shortage
MOUNJARO
10MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541084 · since Mar 17, 2025, no end estimate · Other (Please describe in comments)
Active shortage
MOUNJARO
7.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541076 · since Mar 5, 2025, no end estimate · Other (Please describe in comments)
Active shortage
MOUNJARO
5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541068 · since Oct 1, 2025, no end estimate · Other (Please describe in comments)
Active shortage
MOUNJARO
2.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541041 · since Oct 1, 2025, no end estimate · Other (Please describe in comments)
Resolved
MOUNJARO
15MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541106 · ended Dec 2, 2024 · Other (Please describe in comments)
Resolved
MOUNJARO
12.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541092 · ended Dec 2, 2024 · Other (Please describe in comments)
Resolved
MOUNJARO
7.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541076 · ended Aug 30, 2024 · Other (Please describe in comments)
Resolved
MOUNJARO
10MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541084 · ended Aug 30, 2024 · Other (Please describe in comments)
Resolved
MOUNJARO
2.5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541041 · ended Jun 17, 2024 · Other (Please describe in comments)
Resolved
MOUNJARO
5MG · SOLUTION · ELI LILLY CANADA INC
DIN 02541068 · ended Jun 17, 2024 · Other (Please describe in comments)

What's happening

Tirzepatide is currently affected by 6 active shortage reports filed with Health Canada by ELI LILLY CANADA INC.

The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Tirzepatide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Tirzepatide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Partial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affectedPartial shortageMetformin3 of 33 reported products affected · est. return May 15, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.